Invention Grant
![Substituted pyrido[3,4-b]pyrazines as GPR6 modulators](/docs/US/2020-08-11/US10738046B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
-
Application No.: US16057350Application Date: 2018-08-07
-
Publication No.: US10738046B2Publication Date: 2020-08-11
- Inventor: Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Kristin Schleicher , Huikai Sun , Todd Macklin
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Barnes & Thornburg LLP
- Agent Scott D. Rothenberger
- Main IPC: C07D471/04
- IPC: C07D471/04
![Substituted pyrido[3,4-b]pyrazines as GPR6 modulators](/abs-image/US/2020/08/11/US10738046B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
Public/Granted literature
- US20180346464A1 SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS Public/Granted day:2018-12-06
Information query
